Cancer Immunology Program

This program is led by Pramod Srivastava, Ph.D., and includes nine doctorally prepared scientists or physician-scientists engaged in basic and translational research.

Investigators in The Center for Immunotherapy of Cancer and Infectious Disease study basic mechanisms of immune response, and their application to treatment of cancers. The research addresses NK cell function, T cell priming, induction of tolerance, innate immunity, antigen processing and presentation.

This program serves as the paradigm for translational research. There are vaccine trials in CML, ovarian cancer, renal cell, melanoma and cervical pre-invasive neoplasia.